Unlock open and closed claims data with taXOnomy: Claim better outreach
In the evolving world of real-world data (RWD), pharmaceutical companies are increasingly focused...
In the evolving world of real-world data (RWD), pharmaceutical companies are increasingly focused...
In our series exploring the benefits, considerations and use cases for various types of real-world...
Background While the COVID-19 pandemic is behind us, the virus remains a concern that needs to be...
The healthcare industry has moved away from paper charts and file folders in favor of electronic...
As high-value therapies become the new norm,life sciences teams need closed claims data that...
HealthVerity COO Andrew Goldberg recently sat down with Quest Diagnostics’ Director, Health...
The FDA often requires some sort of post-market surveillance for medical devices to determine the...
Real-world data (RWD) offers a multitude of use cases that can benefit pharmaceutical companies...
Our series exploring the value of real-world data (RWD) throughout the pharmaceutical product life...
In our ongoing series, we have been discussing the value of real-world data (RWD) throughout the...
Few areas of medicine have captured public interest over the past two years quite like glucagon-like peptide-1 (GLP-1) receptor agonists. Originally developed to improve glycemic control in type 2 diabetes, drugs like semaglutide (Ozempic/Wegovy) and...